Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
2.340
+0.170 (7.83%)
Nov 20, 2025, 4:00 PM EST - Market closed
Palisade Bio Market Cap
Palisade Bio has a market cap or net worth of $348.67 million as of November 21, 2025. Its market cap has increased by 10,264.85% in one year.
Market Cap
348.67M
Enterprise Value
343.65M
1-Year Change
10,264.85%
Ranking
Category
Stock Price
$2.34
Market Cap Chart
Since April 28, 2021, Palisade Bio's market cap has increased from $75.07M to $348.67M, an increase of 364.47%. That is a compound annual growth rate of 39.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2025 | 348.67M | 7,539.74% |
| Dec 31, 2024 | 4.56M | -16.56% |
| Dec 29, 2023 | 5.47M | -31.77% |
| Dec 30, 2022 | 8.02M | -54.57% |
| Dec 31, 2021 | 17.65M | -76.49% |
| Apr 28, 2021 | 75.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 934.14B |
| Johnson & Johnson | 489.26B |
| AbbVie | 405.53B |
| UnitedHealth Group | 282.20B |
| AstraZeneca | 277.11B |
| Novartis AG | 239.24B |
| Merck & Co. | 235.72B |
| Abbott Laboratories | 215.57B |